nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—ATP1A1—oviduct—ovarian cancer	0.0333	0.0808	CbGeAlD
Hydroflumethiazide—KCNMA1—myometrium—ovarian cancer	0.0166	0.0402	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—ovarian cancer	0.0144	0.0349	CbGeAlD
Hydroflumethiazide—Vertigo—Altretamine—ovarian cancer	0.0142	0.0242	CcSEcCtD
Hydroflumethiazide—Leukopenia—Altretamine—ovarian cancer	0.0141	0.0241	CcSEcCtD
Hydroflumethiazide—SLC12A3—female reproductive system—ovarian cancer	0.014	0.0339	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Chlorambucil—ovarian cancer	0.0138	0.0236	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Chlorambucil—ovarian cancer	0.0131	0.0223	CcSEcCtD
Hydroflumethiazide—KCNMA1—epithelium—ovarian cancer	0.013	0.0316	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Altretamine—ovarian cancer	0.0126	0.0215	CcSEcCtD
Hydroflumethiazide—CA9—female reproductive system—ovarian cancer	0.0125	0.0304	CbGeAlD
Hydroflumethiazide—KCNMA1—decidua—ovarian cancer	0.0123	0.0298	CbGeAlD
Hydroflumethiazide—Anorexia—Altretamine—ovarian cancer	0.0123	0.0209	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Melphalan—ovarian cancer	0.0121	0.0205	CcSEcCtD
Hydroflumethiazide—Vasculitis—Melphalan—ovarian cancer	0.0115	0.0195	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Melphalan—ovarian cancer	0.0114	0.0194	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Altretamine—ovarian cancer	0.0112	0.0191	CcSEcCtD
Hydroflumethiazide—KCNMA1—gonad—ovarian cancer	0.0108	0.0263	CbGeAlD
Hydroflumethiazide—KCNMA1—uterus—ovarian cancer	0.0108	0.0261	CbGeAlD
Hydroflumethiazide—ATP1A1—myometrium—ovarian cancer	0.0107	0.0259	CbGeAlD
Hydroflumethiazide—ATP1A1—embryo—ovarian cancer	0.0103	0.0249	CbGeAlD
Hydroflumethiazide—CA9—testis—ovarian cancer	0.0101	0.0245	CbGeAlD
Hydroflumethiazide—KCNMA1—female reproductive system—ovarian cancer	0.00968	0.0235	CbGeAlD
Hydroflumethiazide—CA5B—gonad—ovarian cancer	0.00932	0.0226	CbGeAlD
Hydroflumethiazide—CA12—female reproductive system—ovarian cancer	0.00928	0.0225	CbGeAlD
Hydroflumethiazide—Asthenia—Altretamine—ovarian cancer	0.00925	0.0157	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00918	0.0156	CcSEcCtD
Hydroflumethiazide—SLC12A1—testis—ovarian cancer	0.00862	0.0209	CbGeAlD
Hydroflumethiazide—Dizziness—Altretamine—ovarian cancer	0.00852	0.0145	CcSEcCtD
Hydroflumethiazide—ATP1A1—epithelium—ovarian cancer	0.00837	0.0203	CbGeAlD
Hydroflumethiazide—CA5B—female reproductive system—ovarian cancer	0.00832	0.0202	CbGeAlD
Hydroflumethiazide—ATP1A1—uterine cervix—ovarian cancer	0.0083	0.0201	CbGeAlD
Hydroflumethiazide—Vomiting—Altretamine—ovarian cancer	0.0082	0.0139	CcSEcCtD
Hydroflumethiazide—ATP1A1—decidua—ovarian cancer	0.00791	0.0192	CbGeAlD
Hydroflumethiazide—CA2—embryo—ovarian cancer	0.00786	0.0191	CbGeAlD
Hydroflumethiazide—KCNMA1—testis—ovarian cancer	0.00781	0.0189	CbGeAlD
Hydroflumethiazide—Nausea—Altretamine—ovarian cancer	0.00766	0.013	CcSEcCtD
Hydroflumethiazide—CA5B—vagina—ovarian cancer	0.00753	0.0183	CbGeAlD
Hydroflumethiazide—ATP1A1—endometrium—ovarian cancer	0.00751	0.0182	CbGeAlD
Hydroflumethiazide—Cramp muscle—Topotecan—ovarian cancer	0.00747	0.0127	CcSEcCtD
Hydroflumethiazide—CA1—female reproductive system—ovarian cancer	0.00735	0.0178	CbGeAlD
Hydroflumethiazide—Jaundice—Chlorambucil—ovarian cancer	0.007	0.0119	CcSEcCtD
Hydroflumethiazide—ATP1A1—gonad—ovarian cancer	0.00696	0.0169	CbGeAlD
Hydroflumethiazide—CA1—bone marrow—ovarian cancer	0.00694	0.0168	CbGeAlD
Hydroflumethiazide—ATP1A1—uterus—ovarian cancer	0.00692	0.0168	CbGeAlD
Hydroflumethiazide—CA5B—testis—ovarian cancer	0.00672	0.0163	CbGeAlD
Hydroflumethiazide—CA2—epithelium—ovarian cancer	0.00641	0.0155	CbGeAlD
Hydroflumethiazide—ATP1A1—female reproductive system—ovarian cancer	0.00622	0.0151	CbGeAlD
Hydroflumethiazide—Jaundice—Melphalan—ovarian cancer	0.0061	0.0104	CcSEcCtD
Hydroflumethiazide—CA2—decidua—ovarian cancer	0.00606	0.0147	CbGeAlD
Hydroflumethiazide—Pancreatitis—Vinorelbine—ovarian cancer	0.00601	0.0102	CcSEcCtD
Hydroflumethiazide—ATP1A1—bone marrow—ovarian cancer	0.00587	0.0142	CbGeAlD
Hydroflumethiazide—CA4—female reproductive system—ovarian cancer	0.00575	0.0139	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—ovarian cancer	0.00566	0.0137	CbGeAlD
Hydroflumethiazide—ATP1A1—female gonad—ovarian cancer	0.00566	0.0137	CbGeAlD
Hydroflumethiazide—ATP1A1—vagina—ovarian cancer	0.00562	0.0136	CbGeAlD
Hydroflumethiazide—CA4—bone marrow—ovarian cancer	0.00542	0.0132	CbGeAlD
Hydroflumethiazide—CA4—female gonad—ovarian cancer	0.00523	0.0127	CbGeAlD
Hydroflumethiazide—Agitation—Chlorambucil—ovarian cancer	0.00516	0.00878	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Vinorelbine—ovarian cancer	0.0051	0.00869	CcSEcCtD
Hydroflumethiazide—Leukopenia—Chlorambucil—ovarian cancer	0.00502	0.00855	CcSEcCtD
Hydroflumethiazide—ATP1A1—testis—ovarian cancer	0.00502	0.0122	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—ovarian cancer	0.00487	0.0118	CbGeAlD
Hydroflumethiazide—Muscle spasms—Topotecan—ovarian cancer	0.0048	0.00818	CcSEcCtD
Hydroflumethiazide—CA2—female reproductive system—ovarian cancer	0.00476	0.0116	CbGeAlD
Hydroflumethiazide—Glycosuria—Epirubicin—ovarian cancer	0.00464	0.0079	CcSEcCtD
Hydroflumethiazide—CA4—testis—ovarian cancer	0.00464	0.0112	CbGeAlD
Hydroflumethiazide—CA2—bone marrow—ovarian cancer	0.0045	0.0109	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00449	0.00763	CcSEcCtD
Hydroflumethiazide—Leukopenia—Topotecan—ovarian cancer	0.00447	0.00761	CcSEcCtD
Hydroflumethiazide—Leukopenia—Melphalan—ovarian cancer	0.00438	0.00745	CcSEcCtD
Hydroflumethiazide—Anorexia—Chlorambucil—ovarian cancer	0.00437	0.00743	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00436	0.00742	CcSEcCtD
Hydroflumethiazide—CA2—female gonad—ovarian cancer	0.00434	0.0105	CbGeAlD
Hydroflumethiazide—CA2—vagina—ovarian cancer	0.00431	0.0104	CbGeAlD
Hydroflumethiazide—CA1—lymph node—ovarian cancer	0.0043	0.0104	CbGeAlD
Hydroflumethiazide—Cramp muscle—Paclitaxel—ovarian cancer	0.0043	0.00732	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—ovarian cancer	0.00429	0.00731	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00428	0.00728	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—ovarian cancer	0.00405	0.0069	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Paclitaxel—ovarian cancer	0.00405	0.00689	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Topotecan—ovarian cancer	0.00399	0.0068	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Chlorambucil—ovarian cancer	0.00398	0.00678	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00396	0.00674	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Melphalan—ovarian cancer	0.00391	0.00666	CcSEcCtD
Hydroflumethiazide—Anorexia—Topotecan—ovarian cancer	0.00389	0.00662	CcSEcCtD
Hydroflumethiazide—CA2—testis—ovarian cancer	0.00385	0.00932	CbGeAlD
Hydroflumethiazide—Vertigo—Vinorelbine—ovarian cancer	0.00384	0.00654	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—ovarian cancer	0.00383	0.00652	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vinorelbine—ovarian cancer	0.00383	0.00651	CcSEcCtD
Hydroflumethiazide—Anorexia—Melphalan—ovarian cancer	0.00381	0.00648	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00377	0.00641	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—ovarian cancer	0.00375	0.00638	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00372	0.00634	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0037	0.00629	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Docetaxel—ovarian cancer	0.00364	0.0062	CcSEcCtD
Hydroflumethiazide—Urticaria—Chlorambucil—ovarian cancer	0.00364	0.00619	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—ovarian cancer	0.00364	0.00882	CbGeAlD
Hydroflumethiazide—Decreased appetite—Topotecan—ovarian cancer	0.00355	0.00603	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—ovarian cancer	0.00354	0.00603	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—ovarian cancer	0.00353	0.00601	CcSEcCtD
Hydroflumethiazide—Constipation—Topotecan—ovarian cancer	0.00349	0.00594	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Melphalan—ovarian cancer	0.00347	0.00591	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00342	0.00581	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00338	0.00574	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—ovarian cancer	0.00336	0.00815	CbGeAlD
Hydroflumethiazide—Anorexia—Vinorelbine—ovarian cancer	0.00333	0.00566	CcSEcCtD
Hydroflumethiazide—Asthenia—Chlorambucil—ovarian cancer	0.00329	0.00559	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00327	0.00556	CcSEcCtD
Hydroflumethiazide—Urticaria—Topotecan—ovarian cancer	0.00324	0.00551	CcSEcCtD
Hydroflumethiazide—Urticaria—Melphalan—ovarian cancer	0.00317	0.0054	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Chlorambucil—ovarian cancer	0.00313	0.00534	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—ovarian cancer	0.00311	0.00529	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—ovarian cancer	0.00305	0.00519	CcSEcCtD
Hydroflumethiazide—Jaundice—Docetaxel—ovarian cancer	0.00304	0.00517	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinorelbine—ovarian cancer	0.00303	0.00516	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Topotecan—ovarian cancer	0.003	0.00511	CcSEcCtD
Hydroflumethiazide—Constipation—Vinorelbine—ovarian cancer	0.00298	0.00508	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Melphalan—ovarian cancer	0.00294	0.00501	CcSEcCtD
Hydroflumethiazide—Asthenia—Topotecan—ovarian cancer	0.00293	0.00498	CcSEcCtD
Hydroflumethiazide—Vomiting—Chlorambucil—ovarian cancer	0.00291	0.00496	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Docetaxel—ovarian cancer	0.00291	0.00495	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—ovarian cancer	0.00288	0.0049	CcSEcCtD
Hydroflumethiazide—Asthenia—Melphalan—ovarian cancer	0.00287	0.00488	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—ovarian cancer	0.00283	0.00482	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—ovarian cancer	0.00282	0.00481	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Topotecan—ovarian cancer	0.00279	0.00475	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—ovarian cancer	0.00279	0.00676	CbGeAlD
Hydroflumethiazide—Urticaria—Vinorelbine—ovarian cancer	0.00277	0.00472	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Paclitaxel—ovarian cancer	0.00276	0.00471	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Melphalan—ovarian cancer	0.00273	0.00465	CcSEcCtD
Hydroflumethiazide—Nausea—Chlorambucil—ovarian cancer	0.00272	0.00463	CcSEcCtD
Hydroflumethiazide—Dizziness—Topotecan—ovarian cancer	0.0027	0.00459	CcSEcCtD
Hydroflumethiazide—Agitation—Paclitaxel—ovarian cancer	0.00264	0.0045	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—ovarian cancer	0.00262	0.00446	CcSEcCtD
Hydroflumethiazide—Vomiting—Topotecan—ovarian cancer	0.00259	0.00441	CcSEcCtD
Hydroflumethiazide—Vertigo—Paclitaxel—ovarian cancer	0.00258	0.0044	CcSEcCtD
Hydroflumethiazide—Leukopenia—Paclitaxel—ovarian cancer	0.00257	0.00438	CcSEcCtD
Hydroflumethiazide—Rash—Topotecan—ovarian cancer	0.00257	0.00438	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00257	0.00438	CcSEcCtD
Hydroflumethiazide—Dermatitis—Topotecan—ovarian cancer	0.00257	0.00437	CcSEcCtD
Hydroflumethiazide—Headache—Topotecan—ovarian cancer	0.00255	0.00435	CcSEcCtD
Hydroflumethiazide—Vomiting—Melphalan—ovarian cancer	0.00254	0.00432	CcSEcCtD
Hydroflumethiazide—Rash—Melphalan—ovarian cancer	0.00252	0.00429	CcSEcCtD
Hydroflumethiazide—Dermatitis—Melphalan—ovarian cancer	0.00252	0.00428	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinorelbine—ovarian cancer	0.0025	0.00426	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00249	0.00424	CcSEcCtD
Hydroflumethiazide—Nausea—Topotecan—ovarian cancer	0.00242	0.00412	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinorelbine—ovarian cancer	0.00239	0.00406	CcSEcCtD
Hydroflumethiazide—Nausea—Melphalan—ovarian cancer	0.00237	0.00404	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Docetaxel—ovarian cancer	0.00234	0.00399	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—ovarian cancer	0.00231	0.00394	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinorelbine—ovarian cancer	0.00231	0.00393	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00231	0.00393	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.0023	0.00391	CcSEcCtD
Hydroflumethiazide—Anorexia—Paclitaxel—ovarian cancer	0.00224	0.00381	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinorelbine—ovarian cancer	0.00222	0.00378	CcSEcCtD
Hydroflumethiazide—Rash—Vinorelbine—ovarian cancer	0.0022	0.00374	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vinorelbine—ovarian cancer	0.0022	0.00374	CcSEcCtD
Hydroflumethiazide—Headache—Vinorelbine—ovarian cancer	0.00219	0.00372	CcSEcCtD
Hydroflumethiazide—Leukopenia—Docetaxel—ovarian cancer	0.00218	0.00371	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00215	0.00367	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—ovarian cancer	0.00214	0.00364	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—ovarian cancer	0.00213	0.00362	CcSEcCtD
Hydroflumethiazide—Nausea—Vinorelbine—ovarian cancer	0.00207	0.00353	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—ovarian cancer	0.00205	0.00349	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Paclitaxel—ovarian cancer	0.00204	0.00347	CcSEcCtD
Hydroflumethiazide—Constipation—Paclitaxel—ovarian cancer	0.00201	0.00342	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00199	0.00339	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00197	0.00335	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—ovarian cancer	0.00196	0.00334	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Docetaxel—ovarian cancer	0.00195	0.00331	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—ovarian cancer	0.0019	0.00323	CcSEcCtD
Hydroflumethiazide—Anorexia—Docetaxel—ovarian cancer	0.0019	0.00323	CcSEcCtD
Hydroflumethiazide—Urticaria—Paclitaxel—ovarian cancer	0.00186	0.00317	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—ovarian cancer	0.00182	0.00309	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Docetaxel—ovarian cancer	0.00173	0.00294	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00173	0.00294	CcSEcCtD
Hydroflumethiazide—Constipation—Docetaxel—ovarian cancer	0.0017	0.0029	CcSEcCtD
Hydroflumethiazide—Asthenia—Paclitaxel—ovarian cancer	0.00168	0.00287	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Paclitaxel—ovarian cancer	0.00161	0.00273	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—ovarian cancer	0.00158	0.00269	CcSEcCtD
Hydroflumethiazide—Dizziness—Paclitaxel—ovarian cancer	0.00155	0.00264	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—ovarian cancer	0.00151	0.00257	CcSEcCtD
Hydroflumethiazide—Vomiting—Paclitaxel—ovarian cancer	0.00149	0.00254	CcSEcCtD
Hydroflumethiazide—Rash—Paclitaxel—ovarian cancer	0.00148	0.00252	CcSEcCtD
Hydroflumethiazide—Dermatitis—Paclitaxel—ovarian cancer	0.00148	0.00252	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—ovarian cancer	0.00148	0.00251	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—ovarian cancer	0.00147	0.0025	CcSEcCtD
Hydroflumethiazide—Headache—Paclitaxel—ovarian cancer	0.00147	0.0025	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Docetaxel—ovarian cancer	0.00147	0.00249	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—ovarian cancer	0.00146	0.00249	CcSEcCtD
Hydroflumethiazide—Asthenia—Docetaxel—ovarian cancer	0.00143	0.00243	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—ovarian cancer	0.0014	0.00238	CcSEcCtD
Hydroflumethiazide—Nausea—Paclitaxel—ovarian cancer	0.00139	0.00237	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—ovarian cancer	0.00137	0.00233	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—ovarian cancer	0.00136	0.00232	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Docetaxel—ovarian cancer	0.00136	0.00232	CcSEcCtD
Hydroflumethiazide—Dizziness—Docetaxel—ovarian cancer	0.00132	0.00224	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—ovarian cancer	0.00131	0.00224	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—ovarian cancer	0.00128	0.00218	CcSEcCtD
Hydroflumethiazide—Vomiting—Docetaxel—ovarian cancer	0.00126	0.00215	CcSEcCtD
Hydroflumethiazide—Rash—Docetaxel—ovarian cancer	0.00125	0.00213	CcSEcCtD
Hydroflumethiazide—Dermatitis—Docetaxel—ovarian cancer	0.00125	0.00213	CcSEcCtD
Hydroflumethiazide—Headache—Docetaxel—ovarian cancer	0.00125	0.00212	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00122	0.00207	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—ovarian cancer	0.00118	0.00201	CcSEcCtD
Hydroflumethiazide—Nausea—Docetaxel—ovarian cancer	0.00118	0.00201	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—ovarian cancer	0.00117	0.00199	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—ovarian cancer	0.00115	0.00195	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—ovarian cancer	0.00108	0.00184	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—ovarian cancer	0.00107	0.00181	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—ovarian cancer	0.00106	0.00181	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—ovarian cancer	0.000988	0.00168	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—ovarian cancer	0.000986	0.00168	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—ovarian cancer	0.000963	0.00164	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—ovarian cancer	0.000918	0.00156	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000915	0.00156	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—ovarian cancer	0.000891	0.00152	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—ovarian cancer	0.000887	0.00151	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—ovarian cancer	0.000853	0.00145	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—ovarian cancer	0.000849	0.00145	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—ovarian cancer	0.000846	0.00144	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—ovarian cancer	0.000845	0.00144	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—ovarian cancer	0.00084	0.00143	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—ovarian cancer	0.000821	0.0014	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—ovarian cancer	0.000797	0.00136	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—ovarian cancer	0.000789	0.00134	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—ovarian cancer	0.000783	0.00133	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—ovarian cancer	0.000782	0.00133	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—ovarian cancer	0.000778	0.00132	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—ovarian cancer	0.000737	0.00126	CcSEcCtD
